- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | With FDA rejections, Aquestive's shares go up, while Pharming's go down | ||
| Mo | FDA emphasizes drug ingredients, production pledges as it debuts PreCheck manufacturing program | ||
| Mo | Regulatory tracker: FDA sets decision date for Summit's PD-1xVEGF bid | ||
| 30.01. | Trump administration officials are at loggerheads over future of COVID vaccines: Axios | ||
| 30.01. | CHMP thumbs-up Novo's semaglutide for MASH, as Amgen gets Tavneos re-review on data integrity concerns | ||
| 30.01. | A sales turnaround for Regeneron's Eylea franchise will have to wait at least another quarter | ||
| 30.01. | Lilly rounds out quartet of new US plants with $3.5B injectable and device facility in PA | ||
| 30.01. | Quince Therapeutics on the brink as steroid-in-blood-cell fails in rare genetic disease | ||
| 29.01. | Novo gets Chamber of Commerce backing in bid to bring IRA challenge to Supreme Court | ||
| 29.01. | Hims & Hers uses another Super Bowl ad to tackle healthcare affordability | ||
| 29.01. | Takeda, still in a Vyvanse slog, lifts guidance as it looks to new wave of growth | ||
| 29.01. | ARS Pharma TV ad for epinephrine nasal spray Neffy needled by FDA in untitled letter | ||
| 29.01. | Sanofi's vaccine ambitions unfazed by 'politics or sentiment in the now,' CEO Hudson says | ||
| 29.01. | As Roche eyes busy 2026, Vabysmo undershoots targets and Tecentriq fails early lung cancer study | ||
| 29.01. | Bayer broadcasts patient stories with Tony Romo calling plays in Nubeqa drive | ||
| 28.01. | The new rules of biopharma M&A: 4 trends driving dealmaking this year | ||
| 28.01. | Advocacy group files FOIA lawsuit to gain further clarity on Trump administration's MFN pricing deals | ||
| 28.01. | Halozyme catches M&A wave to snap up Surf Bio in delivery tech deal worth up to $400M | ||
| 28.01. | Antheia seals 2nd series C funding close, hitting more than $175M in a year | ||
| 28.01. | Teva, after third straight year of growth, expects downturn in 2026 | ||
| 28.01. | Ro serves up Super Bowl GLP-1 campaign starring Serena Williams | ||
| 28.01. | Cellares' series D round draws $257M as cell therapy contractor takes operations global | ||
| 27.01. | China regulators suspend sale of Sun Pharma's dementia med after site inspection | ||
| 27.01. | EU looks to knock out pharmaceutical export tariffs in sweeping free trade pact with India | ||
| 27.01. | Servier delivers 16% revenue jump, firming up €10B ambition by 2030 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.